An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Vicarious Surgical Inc. (NYSE: RBOT) will announce its third quarter 2021 financial results on November 8, 2021, after market close. A conference call will follow at 4:30 p.m. ET. The company focuses on enhancing surgical procedures through innovative robotics technology, aiming to improve patient outcomes while lowering costs. Vicarious Surgical's system, which combines human-like robots and virtual reality, has received FDA's Breakthrough Device Designation, marking a significant achievement in surgical technology.
Positive
FDA granted Breakthrough Device Designation for Vicarious System.
Innovative approach using human-like robots and virtual reality to enhance surgical procedures.
Negative
None.
WALTHAM, Mass.--(BUSINESS WIRE)--
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced it will report financial results for the third quarter 2021 after the market closes on Monday, November 8, 2021. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by dialing 1 (646) 904 5544 for domestic callers or + 1 (929) 526 1599 for international callers, using access code: 628160. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com/.
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass. Learn more at www.vicarioussurgical.com.
When will Vicarious Surgical report its Q3 2021 financial results?
Vicarious Surgical will report its Q3 2021 financial results on November 8, 2021.
What time is the Vicarious Surgical conference call for Q3 results?
The conference call for Vicarious Surgical's Q3 results will begin at 4:30 p.m. ET.
What is the significance of the Breakthrough Device Designation for RBOT?
The Breakthrough Device Designation from the FDA indicates Vicarious Surgical's technology is innovative and potentially improves patient outcomes significantly.
What technology does Vicarious Surgical use in its procedures?
Vicarious Surgical uses a combination of proprietary human-like surgical robots and virtual reality.
